MAPT and Alzheimer disease: It has also been reported that exosomal amyloid peptides accumulate in the brain plaques of Alzheimer's disease (AD) patients [67]; and tau phosphorylated at Thr-181, an established biomarker for AD, is present at elevated levels in exosomes isolated from cerebrospinal fluid specimens of AD patients with mild symptoms [68].